Trial Profile
Clinical Trials Insight: 700054825
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 11 Mar 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin/fenofibrate (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Veloxis Pharmaceuticals
- 11 Mar 2013 Status changed from planning to unconfirmed.
- 24 Mar 2010 New trial record.